After the US Prostate Cancer Prevention Trial found cancer in many men with low levels of prostate specific antigen (PSA), many debated which PSA level should lead to a biopsy ...
Men with low-risk prostate cancer may wait to see if their disease progresses before treating it, an independent panel of experts convened by the U.S. National Institutes of Health (NIH) ...
Pfizer Inc won unanimous expert backing for its Inlyta experimental drug for patients with advanced kidney cancer. A Food and Drug Administration advisory committee voted 13-0 on Wednesday that the ...
After a four-week course of the vasodilator hormone relaxin, kidney function and blood flow immediately improved in lab rats genetically altered to model polycystic kidney disease (PKD), a life-threatening genetic ...
Copyright © 2022 Urology Today.
